Clinical Trial Update: Intravitreal MTX and ZR Regimen in Newly Diagnosed PVRL [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for intravitreal methotrexate (MTX) and ZR regimen in newly diagnosed primary vitreoretinal lymphoma (PVRL).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitreoretinal Lymphoma

Drugs mentioned

• ZR regimen
• intravitreal methotrexate (methotrexate)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Primary Vitreoretinal Lymphoma | Phase 2 | Status: UNKNOWN